Sunnybrook Health Sciences Centre: Alzheimer Disease trials

The registry lists 15 Alzheimer Disease studies with Sunnybrook Health Sciences Centre as lead sponsor. 8 are open to participants now and 0 have results posted.

Phase 2 6Phase 3 3Phase 4 2No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Levetiracetam for Persons at Risk for Alzheimer's DiseaseRecruitingNCT07477431Phase 2
• Combined Brain Stimulation and Methylphenidate Treatment for Apathy in DementiaRecruitingNCT07279740Phase 2
• Cannabidiol Medication Intervention TrialRecruitingNCT06014424Phase 2
• ANNE Vital Sign System Remote Sleep AssessmentRecruitingNCT05669495
• rTMS for Apathy Clinical TrialRecruitingNCT05561205Not applicable
• Nabilone for Agitation Blinded Intervention TrialRecruitingNCT04516057Phase 3
• ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea TestingRecruitingNCT04335994Not applicable
• BEAM: Brain-Eye Amyloid Memory StudyRecruitingNCT02524405
• Fisetin in Mild Alzheimer's DiseaseCompletedNCT07279714Phase 2
• Using Exercise and Electrical Brain Stimulation to Improve Memory in DementiaCompletedNCT03670615Not applicable
• Safety and Efficacy of Nabilone in Alzheimer's DiseaseCompletedNCT02351882Phase 2/3
• Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease PatientsTerminatedNCT02085265Phase 2
• Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's DiseaseCompletedNCT02035982Phase 3
• Memantine for Agitation and Aggression in Severe Alzheimer's DiseaseCompletedNCT00401167Phase 4
• Apathy Associated With Alzheimer's DiseaseCompletedNCT00254033Phase 4